TSLA vs UNH: Which Is the Better Buy?
Side-by-side comparison of Tesla, Inc. and UnitedHealth Group Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-26.
Tesla, Inc. · Consumer Cyclical
$372.11
+45.0% upside to fair value
Med Conviction
Grade C
VS
UnitedHealth Group Incorporated · Healthcare
$375.21
+28.2% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
TSLA has more upside to fair value
(+45.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
TSLA |
UNH |
| Current Price |
$372.11 |
$375.21 |
| Fair Value Estimate |
$539.56 |
$481.06 |
| Upside to Fair Value |
+45.0%
|
+28.2%
|
| Market Cap |
$1,469.7B |
$340.7B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
121.7x
|
15.0x
|
| Price / Sales |
14.2x
|
0.8x
|
| Price / FCF |
209.1x
|
14.4x
|
| Revenue Growth YoY |
+25.5%
|
+0.4%
|
| Gross Margin |
18.9%
|
22.5%
|
| Operating Margin |
4.2%
|
4.8%
|
| Return on Equity |
4.6%
|
14.6%
|
| Dividend Yield |
0% |
2.41% |
| FCF Yield |
0.48%
|
6.95%
|
| Analyst Consensus |
Hold
|
Strong Buy
|
Investment Thesis
Tesla, Inc. designs, manufactures and sells electric vehicles and energy generation and storage systems, operating through Automotive and Energy Generation and Storage segments with 134,785 full-time employees and a market capitalization of $1,469.67 billion at a share price of $372.11. The business quality is mixed: revenue grew 25.5% year over year in the most recent quarter, but earnings fell …
UnitedHealth Group is the largest diversified healthcare enterprise in the United States, operating UnitedHealthcare insurance plans alongside Optum Health, Optum Insight, and Optum Rx, with 390,000 employees and a market capitalization of $340.74 billion. The business quality is high: a 14.6% return on equity, $26.07 in free cash flow per share, and a P/FCF of 14.39 demonstrate strong cash gener…
Accumulation Zones
| Metric |
TSLA |
UNH |
| Zone Low |
$404.67 |
$360.80 |
| Zone High |
$458.63 |
$408.90 |
| In Buy Zone? |
Yes
|
Yes
|